이뮨온시아 보도자료 - 뉴스와이어

기업 뉴스룸

이뮨온시아 보도자료

RSS

2개

2023년 10월 24일 09:00

ImmuneOncia Announces Positive Phase 1a Results of CD47 Monoclonal Antibody IMC-002 in Solid Tumors at ESMO 2023

ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 1a solid tumour clinical trial (IMC-002-K102 Study) of IMC-002, a CD47 monoclonal antibody, at the European Society for Medical Oncology (ESMO 2023) held in Madrid, Spain on Octobe...

2022년 12월 9일 14:32

ImmuneOncia Announces Phase 2 Results of PD-L1 Immune Checkpoint Inhibitor

ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 2 NK/T-cell lymphoma clinical trial of IMC-001, a PD-L1 monoclonal antibody, at the Asian Congress of the European Society for Medical Oncology (ESMO Asia 2022) held in Singapore o...

메뉴 닫기